RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...

This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 and older to protect ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

All of the people in the study took an RSV test between Oct. 1, 2023, and March 31, 2024, and 1,926 people tested positive. There were 3,275 vaccinated people in the study, as determined by ...

GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV ... have also reached the final stage of clinical testing. Moderna meanwhile has also said it intends ...

Here’s what you need to know. While most people who contract RSV can recover at home, some are sick enough to be admitted to ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

This update highlights pivotal events in the health sector, including FDA approvals for heart devices, RSV vaccine success in ...

The study found higher rates of pneumonia and dyspnea in patients with RSV compared with influenza A or B. Limitations include testing variability and lack of data on immunosuppressive disorders ...

To start, the patient's sample is forced through a device causing the adherence ... The patient's sample is applied to the test, and if RSV proteins are present, they adhere to the antibodies ...